Contal Olivier, Poncin William, Vaudan Stéphanie, De Lys Angélique, Takahashi Hiromitsu, Bochet Séverine, Grandin Stéphane, Kehrer Philippe, Charbonnier Florian
School of Health Sciences Haute Ecole de Santé Vaud (HESAV), Haute école spécialisée de Suisse occidentale (HES-SO) University of Applied Sciences and Arts Western Switzerland, Delémont, Switzerland.
Institut de recherche expérimentale et clinique (IREC), pôle de Pneumologie, oto-rhino-laryngologie (ORL) et Dermatologie, Université Catholique de Louvain, Brussels, Belgium.
Front Med (Lausanne). 2021 Apr 20;8:626361. doi: 10.3389/fmed.2021.626361. eCollection 2021.
Telemedicine (TM) for continuous positive airway pressure (CPAP) treated patients may save health-care resources without compromising treatment effectiveness. We assessed the effect of TM (AirView Online System, ResMed) during the CPAP habituation phase on 3-month and 1-year treatment adherence and efficacy in patients with moderate-to-severe obstructive sleep apnea (OSA). At CPAP initiation, 120 patients diagnosed with OSA were randomized to either usual care (UC) or TM during the habituation phase (clinical registration: ISRCTN12865936). Both groups received a first face-to-face appointment with a sleep care giver at CPAP initiation. Within the following month, 2 other physical visits were scheduled in the UC group whereas two phone consultations were planned in the TM group, in which CPAP parameters were remotely adapted. Additional physical visits were programmed at the patient's request. Face-to-face consultations were scheduled at 3 and 12 months after CPAP initiation. The primary outcome was the mean CPAP daily use over the course of 12 months. Twenty of 60 patients stopped CPAP therapy in the UC group vs. 14 of 60 in the TM group ( = 0.24). In per protocol analysis, mean [95% CI] daily CPAP use among 86 patients still using CPAP at 12 months was 279 [237; 321] min in the 38 patients on UC and 279 [247; 311] min in the 43 patients on TM, mean difference [95% CI]: 0 [-52; 52] min, = 0.99. Total consultation time per patient was not different between groups, TM: 163 [147; 178] min, UC: 178 [159; 197] min, difference: -15 [-39; 9] min, = 0.22. Telemedicine during the CPAP habituation phase did not alter daily CPAP use or treatment adherence and did not require more healthcare time. Telemedicine may support clinic attendance for CPAP titration. [ISRCTN], identifier [ISRCTN12865936].
对于持续气道正压通气(CPAP)治疗的患者,远程医疗(TM)可能在不影响治疗效果的情况下节省医疗资源。我们评估了在CPAP适应阶段,使用远程医疗(瑞思迈公司的AirView在线系统)对中重度阻塞性睡眠呼吸暂停(OSA)患者3个月和1年治疗依从性及疗效的影响。在开始使用CPAP时,120例被诊断为OSA的患者在适应阶段被随机分为常规护理(UC)组或远程医疗组(临床注册号:ISRCTN12865936)。两组患者在开始使用CPAP时均与睡眠护理人员进行了首次面对面会诊。在接下来的一个月内,UC组安排了另外2次现场就诊,而远程医疗组则计划进行2次电话咨询,并对CPAP参数进行远程调整。根据患者需求安排了额外的现场就诊。在开始使用CPAP后的3个月和12个月安排了面对面会诊。主要结局指标是12个月期间CPAP的日均使用时间。UC组60例患者中有20例停止了CPAP治疗,而远程医疗组60例中有14例(P = 0.24)。在符合方案分析中,12个月时仍在使用CPAP的86例患者中,38例接受常规护理患者的CPAP日均使用时间平均[95%CI]为279[237;321]分钟,43例接受远程医疗患者为279[247;311]分钟,平均差异[95%CI]:0[-52;52]分钟,P = 0.99。两组患者的人均总咨询时间无差异,远程医疗组:163[147;178]分钟,常规护理组:178[159;197]分钟,差异:-15[-39;9]分钟,P = 0.22。在CPAP适应阶段,远程医疗不会改变CPAP的日均使用时间或治疗依从性,也不需要更多的医疗时间。远程医疗可能有助于CPAP滴定的门诊就诊。[ISRCTN],标识符[ISRCTN12865936]